CoapTech, an LLC established in Maryland, is seeking to raise seed funding to develop the company to stage where it can successfully reach revenue. This amount will allow the company to conduct a study leading to FDA clearance, establish a legitimate training program for scaling the procedure, and demonstrate growth and product adoption in key early segments of its future user base. Within 18-24 months, the company will expect to raise a future round of funding to help scale.
When possible the company will seek non-dilutive funding sources. Investors will have the opportunity to negotiate terms that are mutually agreeable between they and the company.
CoapTech will facilitate investors' utilization of the Maryland BioTech Tax Credit, a 50% credit incentive for qualified investors.